Akili Grabs CE Mark for Children’s Digital ADHD Treatment Post author:Sam Post published:June 22, 2020 Post category:Devices & Diagnostics Letter The FDA last week cleared EndeavorRx for marketing in the U.S. Source: Devices & Diagnostics Letter You Might Also Like J&J to Start Largest Phase 3 Vaccine Trial Yet in September August 20, 2020 Lawmakers Call for Answers on COVID-19 Antibody Test Scams July 22, 2020 FDA Warns Canadian Sterile Drugmaker for Aseptic Practices June 22, 2020
